Andrew Srisuwananukorn

Andrew Srisuwananukorn works at the intersection of hematology (blood disorders and blood cancers) and artificial intelligence, focusing on conditions such as myeloproliferative neoplasms, myelofibrosis, leukemia, and sickle cell disease. His research combines clinical trial work on drug therapies for blood cancers with the development of deep learning and vision-language tools for interpreting pathology images, clinical text, and rare-disease data. Prospective students would likely engage with projects spanning clinical hematology-oncology research and computational/AI methods applied to medical data.

Publication output has grown substantially over the last decade, rising from occasional single-digit yearly counts before 2020 to a sustained higher pace of roughly 9-17 papers per year from 2023 onward.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026